Alain Delcayre

This inventor holds 14 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 6 EPO patents. Top assignees: Genesis Research & Development Corporation Limited, Bn Immunotherapeutics, Inc., Exothera L.l.c.. Active years: 2002-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alain Delcayre. Retrieved from https://idiyas.com/inventor/alain-delcayre

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 (Patent Applications = 3)

% Patents Active = 57.1

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 5)

Average Co-Inventor Count = 1.6

ph-index = 4

Forward Citations = 84(Granted Patents)

Location History:

Auckland, NZ (2002)
San José, CA (US) (2010)
San Jose, CA (US) (2004 - 2023)

Company Filing History:

6 out of 26

Genesis Research & Development Corporation Limited

patents

4 out of 8

Bn Immunotherapeutics, Inc.

Leland Stanford Junior University

patents

Years Active: 2002-2023

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11753652 - Cassette encoding a FPV/brachyury fusion protein (2023-09-12),

2. 11517530 - Therapeutic agents specifically delivered by exosomes for cancer treatment (2022-12-06),

3. 8377688 - Use of MVA to treat prostate cancer (2013-02-19),

4. 8313740 - Methods for treating cancer with a recombinant MVA expressing HER-2 (2012-11-20),

5. 7914792 - Methods and compounds for raising antibodies and for screening antibody repertoires (2011-03-29),

6. 7867483 - Use of MVA to treat prostate cancer (2011-01-11),

7. 7807146 - Methods for treating cancer with a recombinant MVA expressing HER-2 (2010-10-05),

8. 7704964 - Methods and compounds for the targeting of protein to exosomes (2010-04-27),

9. 7192590 - Compounds for treatment of infectious and immune system disorders and methods for their use (2007-03-20),

10. 7041295 - Compounds for treatment of infectious and immune system disorders and methods for their use (2006-05-09),

11. 6716430 - Compositions isolated from M. vaccae and their use in the modulation of immune responses (2004-04-06),

12. 6436898 - Compounds for treatment of infectious and immune system disorders and methods for their use (2002-08-20),

13. 6361776 - Compounds isolated from M. vaccae and their use in modulation of immune responses (2002-03-26),

14. 6358734 - Compounds for treatment of infectious and immune system disorders and methods for their use (2002-03-19),

Title: The Innovative Journey of Alain Delcayre

Introduction: Alain Delcayre, a visionary inventor based in San Jose, CA, has made significant contributions to the field of technology with his groundbreaking innovations.

Latest Patents: Alain Delcayre's latest patents include a cutting-edge artificial intelligence algorithm for autonomous vehicles and a revolutionary wearable device for monitoring health metrics in real-time.

Career Highlights: With over two decades of experience in the tech industry, Alain Delcayre has held key positions in renowned companies such as Apple and Google, where he spearheaded projects that have redefined the way we interact with technology.

Collaborations: Throughout his career, Alain Delcayre has collaborated with leading researchers and engineers from top universities and research institutions worldwide, fostering a culture of innovation and excellence in all his projects.

Conclusion: Alain Delcayre's relentless pursuit of innovation and his passion for pushing the boundaries of technology continue to inspire the next generation of inventors and entrepreneurs in the ever-evolving tech landscape.

Profile summary based on public USPTO records.